Overview
| Uniprot ID | Q86U44 |
| Protein Name | N(6)-adenosine-methyltransferase catalytic subunit METTL3 |
| Gene Name | METTL3 |
| Organism | Homo sapiens |
Kla Sites from experimental identification
| Position |
Flanking peptide |
| 241 |
TKEQQSKKVSQEILE |
| 263 |
KEQSIVEKFRSRGRA |
| 27 |
ERLQRRRKQDSGHLD |
Function
The METTL3-METTL14 heterodimer forms a N6-methyltransferase complex that methylates adenosine residues at the N(6) position of some RNAs and regulates various processes such as the circadian clock, differentiation of embryonic and hematopoietic stem cells, cortical neurogenesis, response to DNA damage, differentiation of T-cells and primary miRNA processing (PubMed:22575960, PubMed:24284625, PubMed:25719671, PubMed:25799998, PubMed:26321680, PubMed:26593424, PubMed:27281194, PubMed:27373337, PubMed:27627798, PubMed:28297716, PubMed:29348140, PubMed:29506078, PubMed:30428350, PubMed:9409616). In the heterodimer formed with METTL14, METTL3 constitutes the catalytic core (PubMed:27281194, PubMed:27373337, PubMed:27627798). N6-methyladenosine (m6A), which takes place at the 5'-[AG]GAC-3' consensus sites of some mRNAs, plays a role in mRNA stability, processing, translation efficiency and editing (PubMed:22575960, PubMed:24284625, PubMed:25719671, PubMed:25799998, PubMed:26321680, PubMed:26593424, PubMed:28297716, PubMed:9409616). M6A acts as a key regulator of mRNA stability: methylation is completed upon the release of mRNA into the nucleoplasm and promotes mRNA destabilization and degradation (PubMed:28637692). In embryonic stem cells (ESCs), m6A methylation of mRNAs encoding key naive pluripotency-promoting transcripts results in transcript destabilization, promoting differentiation of ESCs (By similarity). M6A regulates the length of the circadian clock: acts as an early pace-setter in the circadian loop by putting mRNA production on a fast-track for facilitating nuclear processing, thereby providing an early point of control in setting the dynamics of the feedback loop (By similarity). M6A also regulates circadian regulation of hepatic lipid metabolism (PubMed:30428350). M6A regulates spermatogonial differentiation and meiosis and is essential for male fertility and spermatogenesis (By similarity). Also required for oogenesis (By similarity). Involved in the response to DNA damage: in response to ultraviolet irradiation, METTL3 rapidly catalyzes the formation of m6A on poly(A) transcripts at DNA damage sites, leading to the recruitment of POLK to DNA damage sites (PubMed:28297716). M6A is also required for T-cell homeostasis and differentiation: m6A methylation of transcripts of SOCS family members (SOCS1, SOCS3 and CISH) in naive T-cells promotes mRNA destabilization and degradation, promoting T-cell differentiation (By similarity). Inhibits the type I interferon response by mediating m6A methylation of IFNB (PubMed:30559377). M6A also takes place in other RNA molecules, such as primary miRNA (pri-miRNAs) (PubMed:25799998). Mediates m6A methylation of Xist RNA, thereby participating in random X inactivation: m6A methylation of Xist leads to target YTHDC1 reader on Xist and promote transcription repression activity of Xist (PubMed:27602518). M6A also regulates cortical neurogenesis: m6A methylation of transcripts related to transcription factors, neural stem cells, the cell cycle and neuronal differentiation during brain development promotes their destabilization and decay, promoting differentiation of radial glial cells (By similarity). METTL3 mediates methylation of pri-miRNAs, marking them for recognition and processing by DGCR8 (PubMed:25799998). Acts as a positive regulator of mRNA translation independently of the methyltransferase activity: promotes translation by interacting with the translation initiation machinery in the cytoplasm (PubMed:27117702). Its overexpression in a number of cancer cells suggests that it may participate in cancer cell proliferation by promoting mRNA translation (PubMed:27117702). During human coronavirus SARS-CoV-2 infection, adds m6A modifications in SARS-CoV-2 RNA leading to decreased RIGI binding and subsequently dampening the sensing and activation of innate immune responses (PubMed:33961823)
Protein Sequence
10
MSDTWSSIQA
20
HKKQLDSLRE
30
RLQRRRKQDS
40
GHLDLRNPEA
50
ALSPTFRSDS
60
PVPTAPTSGG
70
PKPSTASAVP
80
ELATDPELEK
90
KLLHHLSDLA
100
LTLPTDAVSI
110
CLAISTPDAP
120
ATQDGVESLL
130
QKFAAQELIE
140
VKRGLLQDDA
150
HPTLVTYADH
160
SKLSAMMGAV
170
AEKKGPGEVA
180
GTVTGQKRRA
190
EQDSTTVAAF
200
ASSLVSGLNS
210
SASEPAKEPA
220
KKSRKHAASD
230
VDLEIESLLN
240
QQSTKEQQSK
250
KVSQEILELL
260
NTTTAKEQSI
270
VEKFRSRGRA
280
QVQEFCDYGT
290
KEECMKASDA
300
DRPCRKLHFR
310
RIINKHTDES
320
LGDCSFLNTC
330
FHMDTCKYVH
340
YEIDACMDSE
350
APGSKDHTPS
360
QELALTQSVG
370
GDSSADRLFP
380
PQWICCDIRY
390
LDVSILGKFA
400
VVMADPPWDI
410
HMELPYGTLT
420
DDEMRRLNIP
430
VLQDDGFLFL
440
WVTGRAMELG
450
RECLNLWGYE
460
RVDEIIWVKT
470
NQLQRIIRTG
480
RTGHWLNHGK
490
EHCLVGVKGN
500
PQGFNQGLDC
510
DVIVAEVRST
520
SHKPDEIYGM
530
IERLSPGTRK
540
IELFGRPHNV
550
QPNWITLGNQ
560
LDGIHLLDPD
570
VVARFKQRYP
580
DGIISKPKNL
Gene Ontology
| Classification |
GO ID |
Description |
| Cellular Component |
GO:0016607 |
nuclear speck |
| Cellular Component |
GO:0005829 |
cytosol |
| Cellular Component |
GO:0016604 |
nuclear body |
| Cellular Component |
GO:0005654 |
nucleoplasm |
| Cellular Component |
GO:0005634 |
nucleus |
| Cellular Component |
GO:0036396 |
RNA N6-methyladenosine methyltransferase complex |
| Molecular Function |
GO:0003729 |
mRNA binding |
| Molecular Function |
GO:0001734 |
mRNA m(6)A methyltransferase activity |
| Molecular Function |
GO:0046982 |
protein heterodimerization activity |
| Molecular Function |
GO:0008173 |
RNA methyltransferase activity |
| Molecular Function |
GO:1904047 |
S-adenosyl-L-methionine binding |
| Biological Process |
GO:0034644 |
cellular response to UV |
| Biological Process |
GO:0007623 |
circadian rhythm |
| Biological Process |
GO:0006974 |
DNA damage response |
| Biological Process |
GO:0009048 |
dosage compensation by inactivation of X chromosome |
| Biological Process |
GO:0098508 |
endothelial to hematopoietic transition |
| Biological Process |
GO:0021861 |
forebrain radial glial cell differentiation |
| Biological Process |
GO:0042063 |
gliogenesis |
| Biological Process |
GO:0045087 |
innate immune response |
| Biological Process |
GO:0061157 |
mRNA destabilization |
| Biological Process |
GO:0016556 |
mRNA modification |
| Biological Process |
GO:0006397 |
mRNA processing |
| Biological Process |
GO:0000398 |
mRNA splicing, via spliceosome |
| Biological Process |
GO:0045746 |
negative regulation of Notch signaling pathway |
| Biological Process |
GO:0060339 |
negative regulation of type I interferon-mediated signaling pathway |
| Biological Process |
GO:0048477 |
oogenesis |
| Biological Process |
GO:1903679 |
positive regulation of cap-independent translational initiation |
| Biological Process |
GO:0045727 |
positive regulation of translation |
| Biological Process |
GO:0031053 |
primary miRNA processing |
| Biological Process |
GO:1902036 |
regulation of hematopoietic stem cell differentiation |
| Biological Process |
GO:0051445 |
regulation of meiotic cell cycle |
| Biological Process |
GO:0045580 |
regulation of T cell differentiation |
| Biological Process |
GO:0001510 |
RNA methylation |
| Biological Process |
GO:0043489 |
RNA stabilization |
| Biological Process |
GO:0007283 |
spermatogenesis |
| Biological Process |
GO:0019827 |
stem cell population maintenance |
Reference
[1] Yang Z, Yan C, Ma J, Peng P, Ren X et al.. Lactylome analysis suggests lactylation-dependent mechanisms of metabolic adaptation in hepatocellular carcinoma.. Nat Metab 5(1):61-79. 2023 Jan. PMID: 36593272.